Go Pro
→ They didn't warn anyone in 1971. This time someone is warning you. (From Reagan Gold Group) (Ad)tc pixel Free URGN Stock Alerts

Urogen Pharma (URGN) Stock Chart & Stock Price History

Urogen Pharma logo
$46.29 -0.67 (-1.43%)
As of 01:14 PM Eastern
This is a fair market value price provided by Massive. Learn more.
Compare

Urogen Pharma Stock Price Performance

The Urogen Pharma (URGN) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has increased 160.79%, with a year-to-date return of 97.65%. In the past month, the stock has increased 20.05%, reflecting recent market activity.

As of the latest close, Urogen Pharma traded at $46.96 with a market cap of $2.29 billion and volume of 1.03 million shares. Five years ago, the stock traded at $15.32, representing a 202.15% increase over that period. At the time, it had a market cap of $320.14 million and a volume of 106,471 shares.

Receive URGN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Urogen Pharma and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
5 Day
Performance
-0.30%
1 Month
Performance
+20.05%
3 Month
Performance
+57.45%
Year-To-Date
Performance
+97.65%
1 Year
Performance
+160.79%
5 Year
Performance
+202.15%

URGN Stock Chart for Monday, August, 10, 2026

URGN Chart by TradingView

Urogen Pharma Stock Price History

Export
DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization
08/07/2026$45.60$46.96
+2.98%		$48.19$45.751.03 million shs$2.29 billion
08/06/2026$46.43$45.60
-1.79%		$48.03$45.511.22 million shs$2.22 billion
08/05/2026$39.92$46.43
+16.31%		$47.84$40.412.48 million shs$2.26 billion
08/04/2026$38.59$39.92
+3.45%		$40.46$38.81734,469 shs$1.94 billion
08/03/2026$38.24$38.59
+0.92%		$39.41$36.68963,331 shs$1.88 billion
07/31/2026$41.09$38.24
-6.94%		$41.11$38.01814,692 shs$1.86 billion
07/30/2026$40.45$41.09
+1.58%		$41.61$40.32778,779 shs$2.00 billion
07/29/2026$40.88$40.45
-1.05%		$41.50$40.04317,741 shs$1.97 billion
07/28/2026$41.46$40.88
-1.40%		$42.15$40.21390,851 shs$1.99 billion
07/27/2026$40.97$41.46
+1.20%		$41.96$40.10517,131 shs$2.02 billion
07/24/2026$42.50$40.97
-3.60%		$42.89$40.78421,323 shs$2.00 billion
07/23/2026$42.06$42.50
+1.05%		$42.69$41.25494,641 shs$2.07 billion
07/22/2026$43.78$42.06
-3.93%		$43.76$42.04486,929 shs$2.05 billion
07/21/2026$41.12$43.78
+6.47%		$43.93$41.201.15 million shs$2.13 billion
07/20/2026$40.23$41.12
+2.21%		$41.92$40.23550,404 shs$2.00 billion
07/17/2026$40.00$40.23
+0.57%		$41.88$39.501.27 million shs$1.96 billion
07/16/2026$39.80$40.00
+0.50%		$41.36$39.541.24 million shs$1.95 billion
07/15/2026$39.19$39.80
+1.56%		$40.87$38.30907,816 shs$1.94 billion
07/14/2026$39.51$39.19
-0.81%		$40.40$38.88556,070 shs$1.91 billion
07/13/2026$38.56$39.51
+2.46%		$40.00$36.81577,222 shs$1.92 billion
07/10/2026$40.23$38.56
-4.15%		$40.35$38.281.28 million shs$1.88 billion
07/09/2026$38.03$40.23
+5.78%		$40.34$38.11617,932 shs$1.96 billion
Related Companies

This page (NASDAQ:URGN) was last updated on 8/10/2026 by MarketBeat.com Staff.
From Our Partners
Here’s the stock symbol I’ve promised
Whitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...
Stansberry Research | Sponsoredtc pixel
Your $29.97 book is free today
Why Some Traders Skip Stocks Entirely You don't need a big account to trade options. In fact, options ca...
Profits Run | Sponsoredtc pixel
China is not hedging. It's escaping.
China's US Treasury holdings have fallen from a peak of $1.32 trillion to roughly $659 billion, an 18-year low...
Behind the Markets | Sponsoredtc pixel
Free Stock Pick: The Company First in Line for America’s New Super Fuel
The U.S. Army and Department of Energy are launching Project Janus - a high-priority initiative ordered by Pre...
Banyan Hill Publishing | Sponsoredtc pixel
Beginner’s Guide to Gold
The Ultimate Beginner's Guide to Gold IRAs Protect Your Retirement Savings Before It's Too Late With This I...
Goldco Direct, LLC | Sponsoredtc pixel
Elon's Terrifying Warning: America Is "1,000% Going Bankrupt"
The national debt just crossed $39 trillion, and Elon Musk - former head of the Department of Government Effic...
American Hartford Gold | Sponsoredtc pixel
I’ll Keep This Short… (Huge AI Opportunity)
Analyst Ross Givens says the top AI opportunity right now isn't Microsoft, Google, Amazon, Apple, or Nvidia - ...
Traders Agency | Sponsoredtc pixel
Forget SpaceX, Elon Is Now Powering the Next Hot IPO
Elon Musk is backing a new AI startup that's quietly growing faster than Tesla, SpaceX, and reportedly 23 time...
Brownstone Research | Sponsoredtc pixel